Analgesic Effects of Intravenous Paracetamol on Labor Pain
NCT ID: NCT01394731
Last Updated: 2011-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
2010-12-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Intravenous Paracetamol in Manament of Labour Pain
NCT04744727
Intravenous Infusion of Paracetamol for Intrapartum Analgesia of Labor
NCT01428375
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
NCT02181387
Labor Induction and Pain Relief With Paracetamol Versus Placebo
NCT05097950
Meperidine Versus Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae
NCT01236651
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Paracetamol 1
Acetaminophen
Paraceatmol 2
Acetaminophen
Meperidine
Meperidine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acetaminophen
Meperidine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* term patients (≥ 37 weeks of gestation)
Exclusion Criteria
* hypertension, pre-eclampsia, eclampsia
* intra-uterine growth retardation
* intrauterine fetal death
* morbid obesity (body mass index ≥ 35)
* allergy to any of the study drugs
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Abdulaziz Medical City
OTHER_GOV
King Abdulaziz University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
King Abdulaziz University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Abdulaziz Medical City
Riyadh, Central, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC08-052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.